Renalytix AI PLC-ADR

13F holders, Q1 2025 (March 31)
1holders −2
0new positions
2sold out
$0.22avg. 13F price*

At the end of Q1 2025, 1 institutions reported holding Renalytix AI PLC-ADR in their 13F filings, down 2 from Q4 2024. 0 opened new positions and 2 sold out. The largest holder was Ironwood Investment Counsel, LLC ($2K).

Company
Renalytix AI PLC-ADR
CUSIP
75973T101
Latest filing quarter
Q3 2025

History

Number of 13F holders

0102030 Q1 2024: 26Q1 2024Q2 2024: 26Q2 2024Q3 2024: 24Q3 2024Q4 2024: 3Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits2$11K

All 13F filers, Q4 2024 → Q1 2025: 57,068 shares sold, net −57,068 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Ironwood Investment Counsel, LLC 0.00% No change 10,000 $2K

"% of holder's portfolio" is RENALYTIX AI PLC-ADR's weight in each manager's 13F, not the share of Renalytix AI PLC-ADR the manager owns.